N/A
N=23
Humeral Shaft Pseudoarthrosis Treated With Bone Autograft Versus Platelet Rich Plasma
Pseudoarthrosis
Bottom Line
View on ClinicalTrials.gov: NCT02520089 ↗Enrolled (actual)
23
Serious AEs
0.0%
Results posted
Jul 2018
Primary outcome: Primary: Stans Scale — 2.7; 3.0 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- bone autograft of iliac crest (Procedure); Platelet Rich Plasma plus bone autograft (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Universidad Autonoma de Nuevo Leon
- Primary completion
- Feb 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Stans Scale |
2.7; 3.0 | — |
| SECONDARY Quick Disability of Arm, Shoulder and Hand |
7.28; 5.32 | — |
Summary
Patients with humeral shaft pseudoarthrosis is going to be treated with a standard protocol with a locking compression plate and bone autograft, and other group of patients treated with platelet rich plasma.
Posteriorly all the patients it will evaluated radiographically and with functional scales for a period of one year.
Eligibility Criteria
Inclusion Criteria
- evolution of 3 months
- initial orthopedic management
- without mental illness
Exclusion Criteria
- osteoporosis
- contralateral or ipsilateral fractures
- previous fracture in same place at least 3 month
- hematologic problems
- liver disease
- cardiac, renal or lung disease
Data sourced from ClinicalTrials.gov (NCT02520089). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.